AOS vs TVRD · P/E 19, rev $1.00B vs rev $2.6M
Smith AO Corporation (AOS) versus Tvardi Therapeutics, Inc. (TVRD) — a side-by-side from cached financials, not a winner call.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
Latest reported AOS revenue for 2026-06-30 was $1.00B. Net income was $124.9M. Revenue was up 6.2% from 2026-03-31 to 2026-06-30. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Latest reported TVRD revenue for 2025-03-31 was $2.6M. Net income was -$4.9M. TVRD currently screens at market cap $0.
AOS currently screens at market cap $9.73B and trailing P/E 19.1. TVRD currently screens at market cap $0.
Not investment advice. Open the AOS and TVRD stock pages for the full models.
Not investment advice.